XFOR
X4 Pharmaceuticals Inc
2.80$
+1.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -87.6% | +0.0% | +212.9% | +44.3% | -2.5% | +74.4% | -25.4% | -37.2% | +0.0% | +5.8% | +316.9% | – | |
| – | +7.5% | -31.5% | +39.6% | -25.0% | +21.8% | -76.6% | +44.1% | +1.6% | +198.8% | +6.3% | +127.9% | – | |
| – | -251.4% | – | -49.9% | -258.3% | – | -374.2% | – | – | – | -143.7% | – | – | |
| – | +337.5% | +68.6% | +127.1% | -31.3% | -55.4% | +7,217.1% | -100.0% | – | +0.0% | +553.3% | +0.0% | – | |
| – | -6.3% | +10.1% | – | -116.4% | -45.9% | -63.6% | – | -224.0% | – | +14.3% | -105.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.5% | -100.0% | – | -100.0% | – | -100.0% | – | +1,443.3% | +68.1% | -100.0% | +3,650.0% | – | |
| – | – | – | – | -157.4% | – | – | – | – | +384.7% | -100.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.